-
Mesothelioma Advocates Note Irony As White House Staffers Relocate to Avoid Asbestos
Mesothelioma victims and all those who advocate for asbestos to be banned in the United States have been frustrated by the Trump Administration’s stance on the carcinogenic material. Though Congress passed a new law in 2016 to give the Environmental Protection Agency (EPA) the authority to ban asbestos, the EPA under President Trump’s administration has
-
UK Study Shows Using Radiation Therapy to Prevent Mesothelioma Metastasis is Not Worth the Risk
Patients diagnosed with malignant pleural mesothelioma require constant medical attention and intervention, and many of the treatments that they receive are invasive. A study published in the Journal of Clinical Oncology reveals that United Kingdom researchers examined whether prophylactic radiation of the chest wall would stop metastases from occurring along the path of these invasive procedures, but
-
Mesothelioma Awareness Changes Firefighter Procedures
There once was a time that firefighters returned to their station house still wearing their gear, which often was covered with mesothelioma-causing asbestos. But since the World Health Organization’s International Agency for Research on Cancer Working Group classified firefighting as a career that is “possibly carcinogenic to humans,” dramatic changes have been made to how uniforms
-
20-Year Study Reveals Longer Peritoneal Mesothelioma Survival With Repeated Chemotherapy Rinse
The introduction of heated intraoperative chemotherapy (HIPEC) following surgical resection of malignant mesothelioma tumors has proven to be a tremendous breakthrough for mesothelioma patients, providing them with a better prognosis and improved quality of life. Now a study conducted by an esteemed mesothelioma researcher has determined that the positive effects can be further extended through
-
New Dosing Regimen Enables Alimta for Mesothelioma Patients With Kidney Disease
People diagnosed with malignant mesothelioma are frequently hampered by previously existing medical conditions. Many have diabetes or heart conditions that make treatment an additional challenge, and mesothelioma patients with poor kidney function have been especially handicapped because they have been unable to benefit from Alimta, which is the chemotherapy medication that has become the gold
-
Exercise and Good Nutrition Make A Difference In Mesothelioma Outcomes
Getting a mesothelioma diagnosis is a traumatic, earth-shattering experience, and it comes as no surprise that many patients respond by shutting down and losing interest in the activities and indulgences that they previously enjoyed. But an Australian study has confirmed what many physicians already suspected: discontinuing eating well and exercising has a direct, negative impact
-
Researchers Explore How Manipulating Diet Affects Cancers Like Mesothelioma
Could a change in diet boost the effectiveness of chemotherapy for patients diagnosed with malignant mesothelioma? That’s the question that researchers in Texas are trying to answer. They hope that by manipulating blood sugar levels using either diabetes drugs or a ketogenic diet, they can starve cancer cells of one of their most important sources
-
Hong Kong Researchers Achieve Longer Mesothelioma Lifespan With Enzyme Inhibitor
Researchers from the University of Hong Kong have just revealed that by using an enzyme inhibitor called DFMO on mice infected with malignant pleural mesothelioma, they were able to extend the animals’ lifespan.
-
Court Decides in Favor of Mesothelioma Victim Exposed to Asbestos At Work and At Home
When Vickie Williams was diagnosed with malignant mesothelioma, she knew exactly where the asbestos she’d been exposed to came from: It all came from the Square D factory. But the exact method of her exposure was a little harder to figure out. Vickie’s father had worked for Schneider Electric USA (formerly known as Square D)
-
Johnson & Johnson Attempts to Deny Link Between Peritoneal Mesothelioma and Asbestos
The latest lawsuit accusing Johnson & Johnson’s Baby Powder of causing malignant mesothelioma is proceeding in a New Jersey courtroom, and as four people diagnosed with the rare and fatal form of cancer testify about their lifelong use of the product, the consumer company’s attorneys are attempting to deny that asbestos causes their form of
-
Australian Asbestos Company’s Mesothelioma Liability Estimated at Over $1.8 Billion
The United States has a long list of companies whose name quickly brings to mind the spectre of mesothelioma and asbestos-related cancers: the W.R. Grace Company tops the list, and there are dozens of others, including Johns Manville and United States Gypsum. In Australia, one of the most notorious of the asbestos companies is James
-
Mesothelioma Patients Greet News that Medicare To Cover CAR-T Therapy
CAR-T is an innovative cancer treatment that is being tested on mesothelioma patients. The protocol involves the stricken patient’s T-cells — part of their immune system — being withdrawn, changed in the lab, and then infused back into the patient. Their genetically modified cells then attack a protein on the surface of their specific cancer’s
-
Nintedanib Study Halted After Disappointing Mesothelioma Trial
Among the various mesothelioma cures being studied around the world, the drug nintedanib showed a great deal of promise. But recent studies have proven so disappointing that a multi center study that included patients across 27 countries has been called to a halt, and patients are being placed on different regimens.
-
As Michigan School District Faces Asbestos Fines, Employees Fear Mesothelioma Risk
While a Michigan public school district considers the impact of a fine for violating asbestos regulations, district employees are wondering whether their employers’ actions have put them at risk for malignant mesothelioma or other asbestos-related diseases. This issue was raised after the Michigan Department of Licensing and Regulatory Affairs (LARA) revealed that the school district
-
Report Shows Variability of Risk Of Mesothelioma Death Based on Type
Italy is one of the many countries in the world that is suffering an epidemic of malignant mesothelioma and other asbestos-related diseases, and as a result, researchers from that country are working diligently to understand how the disease manifests itself, and where the greatest risks lie. A recently published study conducted by the Italian Workers’
-
Johnson & Johnson Baby Powder Trial Jury Hears of Mesothelioma Victim’s Emotional Pain
A New Jersey jury hearing testimony in a mesothelioma lawsuit against consumer giant Johnson & Johnson listened to emotional testimony from one of the four plaintiffs in the case, describing his pain at the knowledge that his children will grow up without him. Will Ronning is one of four plaintiffs in the single trial who
-
Following Mesothelioma Claims, J&J May Need to Add Cancer Warning to Baby Powder
At the heart of the 14,000-plus lawsuits charging Johnson & Johnson’s Baby Powder of causing malignant mesothelioma and ovarian cancer is the fact that the company apparently knew that their product carried a cancer risk, but did nothing to warn consumers of the hazards of using it. Many of the plaintiffs who have already won
-
Judge to Determine Fate of Thousands of Johnson & Johnson’s Talc Powder Lawsuits
The fate of thousands of lawsuits accusing Johnson & Johnson’s talc-based powders of causing malignant mesothelioma and ovarian cancer are in the hands of a federal judge, who is making the determination this week as to which expert witness testimony will be allowed in many of the cases that are pending. Johnson & Johnson is
-
New CAR-T Strategy Holds Promise for Mesothelioma Treatment
CAR-T, or Chimeric Antigen Receptor T-cells, is an innovative treatment that has been getting a lot of attention from cancer researchers, and especially from those seeking an effective treatment for malignant mesothelioma. The protocol takes a patient’s T cells (which are created by their immune system) and engineers them in the laboratory, adding gene for
-
Baylor’s Mesothelioma Treatment Center Announces New Clinical Trial
One of the shining lights in mesothelioma research can be found at the Baylor College of Medicine Lung Institute, where the Houston-based center’s Mesothelioma Treatment Center has long been on the cutting edge of both research and patient care. Now their associate professor of surgery Dr. Bryan Burt is taking their investigations one step further,
